AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Mazzolini, G Narvaiza, I Bustos, M Duarte, M Tirapu, I Bilbao, R Qian, C Prieto, J Melero, I
Citation: G. Mazzolini et al., alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 atthe periphery of hepatic colon cancer metastases induces VCAM-1 expressionand T-cell recruitment, MOL THER, 3(5), 2001, pp. 665-672

Authors: Melero, I Mazzolini, G Narvaiza, I Qian, C Chen, LP Prieto, J
Citation: I. Melero et al., IL-12 gene therapy for cancer: in synergy with other immunotherapies, TRENDS IMMU, 22(3), 2001, pp. 113-115

Authors: Mazzolini, G Narvaiza, I Perez-Diez, A Rodriguez-Calvillo, M Qian, C Sangro, B Ruiz, J Prieto, J Melero, I
Citation: G. Mazzolini et al., Genetic heterogeneity in the toxicity to systemic adenoviral gene transferof interleukin-12, GENE THER, 8(4), 2001, pp. 259-267

Authors: Rodriguez-Calvillo, M Gabari, I Duarte, M Mazzolini, G Rifon, J Rocha, E Prieto, J Melero, I
Citation: M. Rodriguez-calvillo et al., Thrombopenic purpura induced by a monoclonal antibody directed to a 35-kilodalton surface protein (p35) expressed on murine platelets and endothelialcells, EXP HEMATOL, 29(5), 2001, pp. 589-595

Authors: Barajas, M Mazzolini, G Genove, G Bilbao, R Narvaiza, I Schmitz, V Sangro, B Melero, I Qian, C Prieto, J
Citation: M. Barajas et al., Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12, HEPATOLOGY, 33(1), 2001, pp. 52-61

Authors: Casares, N Lasarte, JJ de Cerio, ALD Sarobe, P Ruiz, M Melero, I Prieto, J Borras-Cuesta, F
Citation: N. Casares et al., Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity, EUR J IMMUN, 31(6), 2001, pp. 1780-1789

Authors: Mazzolini, G Qian, C Narvaiza, I Barajas, M Borras-Cuesta, F Xie, XM Duarte, M Melero, I Prieto, J
Citation: G. Mazzolini et al., Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level, HUM GENE TH, 11(1), 2000, pp. 113-125

Authors: Melero, I Vile, RG Colombo, MP
Citation: I. Melero et al., Feeding dendritic cells with tumor antigens: self-service buffet or a la carte?, GENE THER, 7(14), 2000, pp. 1167-1170

Authors: Narvaiza, I Mazzolini, G Barajas, M Duarte, M Zaratiegui, M Qian, C Melero, I Prieto, J
Citation: I. Narvaiza et al., Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-Inducible protein-10 and another encoding IL-12, results in markedantitumoral synergy, J IMMUNOL, 164(6), 2000, pp. 3112-3122

Authors: Melero, I Duarte, M Ruiz, J Sangro, B Galofre, JC Mazzolini, G Bustos, M Qian, C Prieto, J
Citation: I. Melero et al., Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas, GENE THER, 6(10), 1999, pp. 1779-1784

Authors: Melero, I Johnston, JV Shufford, WW Mittler, RS Chen, LP
Citation: I. Melero et al., NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are requiredfor tumor immunity elicited by anti-4-1BB monoclonal antibodies, CELL IMMUN, 190(2), 1998, pp. 167-172
Risultati: 1-11 |